Compound Dibazole Hydrochlorothiazide Capsules
Function and Efficacy
Not yet clear.
Ingredients
Dibazole, promethazine hydrochloride, chloroquine phosphate, guanidine sulfate, vitamin B6, potassium chloride, reserpine, chlordiazepoxide, hydrochlorothiazide, calcium lactate, vitamin B1, magnesium trisilicate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| BendazolIngredients |
Not yet clear More |
621-72-7 | 1 | |
| Promethazine hydrochlorideIngredients |
Not yet clear More |
58-33-3 | 29 | |
| Chloroquine diphosphateIngredients |
Not yet clear More |
50-63-5 | 11 | |
| GUANOXAN SULFATEIngredients |
Not yet clear More |
5714-04-5 | 1 | |
| Vitamin B6Ingredients |
Not yet clear More |
8059-24-3 | 13 | |
| Potassium chlorideIngredients |
Not yet clear More |
7447-40-7 | 38 | |
| ReserpineIngredients |
Not yet clear More |
50-55-5 | 19 | |
| HydrochlorothiazideIngredients |
Not yet clear More |
58-93-5 | 56 | |
| Calcium lactateIngredients |
Not yet clear More |
814-80-2 | 10 | |
| Thiamine chlorideIngredients |
Not yet clear More |
59-43-8 | 9 | |
| Magnesium trisilicateIngredients |
Not yet clear More |
14987-04-3 | 11 |
Appearance
The content of this product is white or off-white granules or powder.
Indication
Used for hypertension.
Usage and Dosage
1. Long-term use of this product may cause diarrhea, dizziness, fatigue, weakness, dry mouth, drowsiness, loss of appetite, nausea, vomiting, nasal congestion, tinnitus, rash, headache, dizziness, depression, bradycardia and other symptoms. If the symptoms persist, you must pay attention. 2. Pay attention to postural hypotension, electrolyte imbalance, hypokalemia, hyponatremia, hypochloremia, etc. 3. This product contains reserpine, which can cause tremor paralysis, mental depression and aggravate the symptoms of gastrointestinal ulcers. 4. The chloramine in this product has withdrawal symptoms. After discontinuation of use, there will be insomnia, abnormal irritability and nervousness. The elderly and weak patients and patients with liver disease are more sensitive to its central inhibitory effect.
Adverse Reactions
1. Pregnant women and lactating women are prohibited from using this product. 2. Infants and young children are prohibited from using this product. 3. Patients with severe liver and kidney dysfunction are prohibited from using this product. 4. Patients with severe heart failure are prohibited from using this product. 5. Patients who are allergic to the ingredients of this product are prohibited from using this product.
Precautions
Not yet clear.
Special Population Medication
Precautions for children: Antihistamines are very dangerous to infants, especially newborns and premature infants, so they are contraindicated for infants and young children. Precautions for pregnancy and lactation: This compound preparation contains promethazine hydrochloride, which can induce jaundice and extrapyramidal symptoms in infants when taken by pregnant women. Animal experiments show that reserpine can cause malformation and carcinogenesis in rat pups. Therefore, it is contraindicated for pregnant and lactating women. Precautions for the elderly: The elderly are sensitive to antihypertensive effects, and their renal function may decrease with age, so the dosage should be reduced as appropriate.
Drug Interactions
If used with other medicines, interactions may occur. Please consult your doctor or pharmacist for details.
Storage
Keep away from light, sealed and stored in a dry place.
Packaging Specification
Each tablet contains 10.0 mg of dimethoate, 3.0 mg of promethazine hydrochloride, 2.5 mg of chloroquine phosphate, 1.2 mg of guanidine sulfate, 1.0 mg of vitamin B6, 30.0 mg of potassium chloride, 0.03 mg of reserpine, 2.0 mg of chlordiazepoxide, 3.0 mg of hydrochlorothiazide, 1.0 mg of calcium lactate, 1.0 mg of vitamin B1, and 30.0 mg of magnesium trisilicate.
Validity Period
24 months
Manufacturer
Shanxi Hcxf Pharmaceutical Co., Ltd.
-
Founded in:
2000-11-02 -
Address:
No. 1 Jingyi Road, Jincheng Development Zone, Shanxi Province -
Tax NO.:
91140500725906918N -
Registered Funds:
84.3 million yuan -
Website:
-
Email: